Octavio Lopez-Ballesta
Av. Fernando Abril Martorell 106
Valencia, VC 46026, Spain
Valencia, VC 46026, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Journal: International journal of molecular sciences
Published: January 16, 2025
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Journal: European journal of hospital pharmacy : science and practice
Published: April 11, 2024
Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leukemia: current landscape.
Journal: Expert review of clinical pharmacology
Published: January 28, 2023
Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: April 05, 2022
Emerging FLT3 inhibitors for the treatment of acute myeloid leukemia.
Journal: Expert opinion on emerging drugs
Published: January 25, 2022
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Journal: Pharmacogenetics and genomics
Published: March 06, 2021
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Journal: European journal of hospital pharmacy : science and practice
Published: February 19, 2021
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain.
Journal: Journal of clinical apheresis
Published: December 21, 2020
Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.
Journal: European journal of haematology
Published: November 28, 2020
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Journal: Leukemia & lymphoma
Published: November 02, 2020
Gilteritinib use in the treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation.
Journal: Future oncology (London, England)
Published: September 25, 2020
Last Updated: 09/26/2026